日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ashwagandha, Withania somnifera (L.) Dunal, for the prophylaxis against SARS-CoV-2 infection: A multicentric randomized hydroxychloroquine controlled clinical trial in Indian health care workers

南非醉茄(Withania somnifera (L.) Dunal)用于预防SARS-CoV-2感染:一项针对印度医护人员的多中心随机羟氯喹对照临床试验

Kulkarni-Munshi, Renuka; Talmohite, Deepti; More, Anand; Chakravarty, Jaya; Kamat, Sandhya; Khobragade, Akash; Reddy, D Himanshu; Patel, Manish; Kajaria, Divya; Singh, Raju; Kumari, Sarita; Mishra, Priyanka; Srivastava, A K; Bhagat, Vivek; Pandey, Saurabh; Yadav, Meena; Darnule, Rahul; Bhat, Shobha; Kansal, Sangeeta; Munot, Sonali; Kumbhar, Dipti; Tripathi, Raakhi; Gajbhiye, Snehalata; Marathe, Padmaja; Parvatkar, Jaee; Shukla, Dhaiwat; Panchal, Prakashkumar; Shah, Jui; Bhale, Jayashree; Sattigeri, Viswajanani; Amarsheda, Ashish; Avhad, Anil; Kshirsagar, Nilima; Mondhe, Dilip M; Chopra, Arvind

A Double-blind Multicenter Two-arm Randomized Placebo-controlled Phase-III Clinical Study to Evaluate the Effectiveness and Safety of Thymosin α1 as an Add-on Treatment to Existing Standard of Care Treatment in Moderate-to-severe COVID-19 Patients

一项双盲、多中心、双臂、随机、安慰剂对照的III期临床研究,旨在评估胸腺素α1作为现有标准治疗方案的附加疗法对中重度COVID-19患者的有效性和安全性。

Shetty, Adarsh; Chandrakant, Nirhali Sonali; Darnule, Rahul Ashok; Manjunath, B G; Sathe, Prachee